Trial Comparing Electric and Harmonic Scalpel in Mastectomy
Launched by BARRETOS CANCER HOSPITAL · Jul 8, 2011
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
The population of this study was formed by women aged older than 18 years old, with breast carcinoma (ductal ou lobular) at any stage, form whom modified radical mastectomy is proposed. Patients were excluded if the present blood dyscrasia, collagen diseases, known uncontrolled chronic disease, infections (mammary or axillary, ulcerated tumors and pregnancy. The women were submitted to modified radical mastectomy consecutive allocated in electric scalpel group and the other group with harmonic scalpel.
Electric scalpels were calibrated at 40 watts of cutting and coagulation power and harmo...
Gender
FEMALE
Eligibility criteria
- • Women with breast cancer candidate to a radical mastectomy during the year of 2008.
- • Prospective trial with women stratified consecutive.
- Inclusion Criteria:
- • Breast carcinoma (ductal or lobular)
- • Modified radical mastectomy was the surgery to be realized
- Exclusion Criteria:
- • Not inclusion criteria
- • Blood dyscrasia, collagen diseases, known uncontrolled chronic diseases, infections (mammary or axillary), ulcerated tumors and pregnancy
About Barretos Cancer Hospital
Barretos Cancer Hospital is a leading healthcare institution dedicated to the comprehensive treatment and research of cancer. Located in Barretos, Brazil, the hospital is renowned for its innovative approaches to oncology, offering state-of-the-art facilities and a multidisciplinary team of experts. As a clinical trial sponsor, Barretos Cancer Hospital is committed to advancing cancer care through rigorous research and the development of new therapeutic options, striving to improve patient outcomes and enhance the quality of life for those affected by cancer. Their focus on collaboration and excellence positions them at the forefront of cancer research in Latin America.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barretos, São Paulo, Brazil
Patients applied
Trial Officials
Edmundo C Mauad, MD, PhD
Study Director
Director from Barretos Cancer Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials